Approval · Notice of Compliance 6805 · 2005
DALMANE: Notice of Compliance 6805
Issued May 16, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6805
- Date
- May 16, 2005
- Company
- Valeant Canada LpLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Hypnotic
Products in this notice
Medicinal ingredients
- FLURAZEPAM HCL 15 MG per TAB
- FLURAZEPAM HCL 30 MG per TAB